Komori
General Meetings of Shareholders4882Perseus Proteomics Inc.Pharmaceuticals

Matters Not Included in the Documents Delivered for the 2026 Annual Shareholders Meeting

Among the materials provided electronically for the Annual Shareholders Meeting, the content and operating status of the internal control system and the notes to the non-consolidated financial statements were disclosed without including them in the documents delivered, in accordance with applicable laws and the Articles of Incorporation. The notes to the non-consolidated financial statements state, among other matters, that the estimated restoration costs were increased by ¥28,299 thousand and the same amount was recorded as an impairment loss under extraordinary losses.

Worth reading
17Immaterial
Scored from 1 of 4 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
28299
¥ thousand
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (26th)
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (26th)
Items this document does not state (5)
Date and timeMatters for resolutionShareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The information was omitted from the documents delivered to shareholders who requested delivery in accordance with applicable laws and Article 15 of the Company's Articles of Incorporation. The estimate of restoration costs was changed because new information was obtained.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Not Included in the Documents Delivered for the 2026 Annual Shareholders Meeting | Perseus Proteomics Inc. (4882) timely disclosure | Komori